PainReform logo

PRFX - PainReform Share Price

$6.5 0.1  1.9%

Last Trade - 24/02/21

Sector
Healthcare
Size
Micro Cap
Market Cap £39.6m
Enterprise Value £48.0m
Revenue £n/a
Position in Universe 5446th / 6714
Bullish
Bearish
Unlock PRFX Revenue
Momentum
Relative Strength (%)
1m +42.6%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -18.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019,PainReform Ltd revenues was not reported. Net lossapplicable to common stockholders increased 29% to $2.4M.Higher net loss reflects Accrued interest on convertiblenotes increase of 67% to $541K (expense), General andadministrative expenses increase of 51% to $418K (expense),Share-based compensation expense increase from $0K to $75K(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PRFX Revenue Unlock PRFX Revenue

Net Income

PRFX Net Income Unlock PRFX Revenue

Normalised EPS

PRFX Normalised EPS Unlock PRFX Revenue

PE Ratio Range

PRFX PE Ratio Range Unlock PRFX Revenue

Dividend Yield Range

PRFX Dividend Yield Range Unlock PRFX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
PRFX EPS Forecasts Unlock PRFX Revenue
Profile Summary

PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated December 2, 2007
No. of Shareholders: n/a
No. of Employees: 3
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 8,758,016
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PRFX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PRFX
Upcoming Events for PRFX
Frequently Asked Questions for PainReform
What is the PainReform share price?

As of 24/02/21, shares in PainReform are trading at $6.5, giving the company a market capitalisation of £39.6m. This share price information is delayed by 15 minutes.

How has the PainReform share price performed this year?

Shares in PainReform are currently trading at $6.5 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the PainReform price has moved by % over the past year.

What are the analyst and broker recommendations for PainReform?

There are no analysts currently covering PainReform.

When will PainReform next release its financial results?

PainReform is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the PainReform dividend yield?

PainReform does not currently pay a dividend.

Does PainReform pay a dividend?

PainReform does not currently pay a dividend.

When does PainReform next pay dividends?

PainReform does not currently pay a dividend.

How do I buy PainReform shares?

To buy shares in PainReform you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of PainReform?

Shares in PainReform are currently trading at $6.5, giving the company a market capitalisation of £39.6m.

Where are PainReform shares listed? Where are PainReform shares listed?

Here are the trading details for PainReform:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: PRFX
What kind of share is PainReform?

Based on an overall assessment of its quality, value and momentum, PainReform is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a PainReform share price forecast 2021?

We were not able to load any forecast data for PainReform.

How can I tell whether the PainReform share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PainReform. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $6.5, shares in PainReform are trading at 31.2% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the PainReform PE Ratio?

We were not able to find PE ratio data for PainReform.

Who are the key directors of PainReform?

We were unable to find the directors for PainReform.

Who are the major shareholders of PainReform?

Here are the top five shareholders of PainReform based on the size of their shareholding:

Medica III Investment group Corporation
Percentage owned: 38.36% (3.36m shares)
XT Holdings Ltd Corporation
Percentage owned: 20.02% (1.75m shares)
Viola Partners Corporation
Percentage owned: 6.52% (571k shares)
Sabby Management, LLC Investment Advisor/Hedge Fund
Percentage owned: 0.7% (61.6k shares)
Pura Vida Investments, LLC Hedge Fund
Percentage owned: 0.11% (10.00k shares)
Similar to PRFX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.